Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand

Nittaya Phanuphak(HIV Netherlands Australia Thailand Research Collaboration), Praphan Phanuphak(Unknown)
Sexual Health
September 24, 2018
10.1071/sh18065
Cited by 130

Related Papers

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
|The Journal of Infectious Diseases|2021|129
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial
|The Lancet|2025|26